FDA Approval Process for Generics Sound, Say Officials

News | 05 December 2012

• Print This

The US Food and Drug Administration's (FDA's) recent recommendation to the manufacturers of generic extended-release bupropion (Budeprion XL 300 mg, Impax Laboratories and Teva Pharmaceuticals) that resulted in its being voluntarily withdrawn from ...

Click on the link to read the full article at Medscape
(This link will open in a new window)